The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance von Meads, Mark B, Hazlehurst, Lori A, Dalton, William S

Volltext

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study von Scott, Jacob G, MD, Berglund, Anders, PhD, Schell, Michael J, Prof, Mihaylov, Ivaylo, PhD, Fulp, William J, MS, Yue, Binglin, MS, Welsh, Eric, PhD, Caudell, Jimmy J, MD, Ahmed, Kamran, MD, Strom, Tobin S, MD, Mellon, Eric, MD, Venkat, Puja, MD, Johnstone, Peter, Prof, Foekens, John, Prof, Lee, Jae, Prof, Moros, Eduardo, Prof, Dalton, William S, Prof, Eschrich, Steven A, PhD, McLeod, Howard, Prof, Harrison, Louis B, Prof, Torres-Roca, Javier F, Dr

Volltext

MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA von Kong, William, Yang, Hua, He, Lili, Zhao, Jian-jun, Coppola, Domenico, Dalton, William S., Cheng, Jin Q.

Volltext

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma von Zhao, Xiaohong, Lwin, Tint, Silva, Ariosto, Shah, Bijal, Tao, Jiangchuan, Fang, Bin, Zhang, Liang, Fu, Kai, Bi, Chengfeng, Li, Jiannong, Jiang, Huijuan, Meads, Mark B., Jacobson, Timothy, Silva, Maria, Distler, Allison, Darville, Lancia, Zhang, Ling, Han, Ying, Rebatchouk, Dmitri, Di Liberto, Maurizio, Moscinski, Lynn C., Koomen, John M., Dalton, William S., Shain, Kenneth H., Wang, Michael, Sotomayor, Eduardo, Tao, Jianguo

Volltext

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma von Zhao, Jian-Jun, Lin, Jianhong, Lwin, Tint, Yang, Hua, Guo, Jianping, Kong, William, Dessureault, Sophie, Moscinski, Lynn C., Rezania, Dorna, Dalton, William S., Sotomayor, Eduardo, Tao, Jianguo, Cheng, Jin Q.

Volltext

BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models von Zhao, Xiaohong, Ren, Yuan, Lawlor, Matthew, Shah, Bijal D., Park, Paul M.C., Lwin, Tint, Wang, Xuefeng, Liu, Kenian, Wang, Michelle, Gao, Jing, Li, Tao, Xu, Mousheng, Silva, Ariosto S., Lee, Kaplan, Zhang, Tinghu, Koomen, John M., Jiang, Huijuan, Sudalagunta, Praneeth R., Meads, Mark B., Cheng, Fengdong, Bi, Chengfeng, Fu, Kai, Fan, Huitao, Dalton, William S., Moscinski, Lynn C., Shain, Kenneth H., Sotomayor, Eduardo M., Wang, Gang Greg, Gray, Nathanael S., Cleveland, John L., Qi, Jun, Tao, Jianguo

Volltext

Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma von Richardson, Paul G, Sonneveld, Pieter, Schuster, Michael W, Irwin, David, Stadtmauer, Edward A, Facon, Thierry, Harousseau, Jean-Luc, Ben-Yehuda, Dina, Lonial, Sagar, Goldschmidt, Hartmut, Reece, Donna, San-Miguel, Jesus F, Bladé, Joan, Boccadoro, Mario, Cavenagh, Jamie, Dalton, William S, Boral, Anthony L, Esseltine, Dixie L, Porter, Jane B, Schenkein, David, Anderson, Kenneth C

Volltext

Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy von Nefedova, Yulia, Sullivan, Daniel M., Bolick, Sophia C., Dalton, William S., Gabrilovich, Dmitry I.

Volltext

β1 Integrin Adhesion Enhances IL-6―Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation von SHAIN, Kenneth H, YARDE, Danielle N, MEADS, Mark B, MEI HUANG, JOVE, Richard, HAZLEHURST, Lori A, DALTON, William S

Volltext

Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors von Turner, Joel G, Dawson, Jana L, Grant, Steven, Shain, Kenneth H, Dalton, William S, Dai, Yun, Meads, Mark, Baz, Rachid, Kauffman, Michael, Shacham, Sharon, Sullivan, Daniel M

Volltext

Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma von Yarde, Danielle N, Oliveira, Vasco, Mathews, Linda, Wang, Xingyu, Villagra, Alejandro, Boulware, David, Shain, Kenneth H, Hazlehurst, Lori A, Alsina, Melissa, Chen, Dung-Tsa, Beg, Amer A, Dalton, William S

Volltext

Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines von Nefedova, Yulia, Cheng, Pingyan, Alsina, Melissa, Dalton, William S., Gabrilovich, Dmitry I.

Volltext

ABCG2 expression, function, and promoter methylation in human multiple myeloma von Turner, Joel G., Gump, Jana L., Zhang, Chunchun, Cook, James M., Marchion, Douglas, Hazlehurst, Lori, Munster, Pamela, Schell, Michael J., Dalton, William S., Sullivan, Daniel M.

Volltext

HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma von Nimmanapalli, Ramadevi, Gerbino, Elvira, Dalton, William S., Gandhi, Varsha, Alsina, Melissa

Volltext

Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death von Hazlehurst, Lori A, Landowski, Terry H, Dalton, William S

Volltext

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells von Catlett-Falcone, Robyn, Landowski, Terry H, Oshiro, Marc M, Turkson, James, Levitzki, Alexander, Savino, Rocco, Ciliberto, Gennaro, Moscinski, Lynn, Fernández-Luna, Jose Luis, Nuñez, Gabriel, Dalton, William S, Jove, Richard

Volltext

Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy von Eljilany, Islam, Coleman, Sam, Tan, Aik Choon, McCarter, Martin D, Carpten, John, Colman, Howard, Naqash, Abdul Rafeh, Puzanov, Igor, Arnold, Susanne M, Churchman, Michelle L, Spakowicz, Daniel, Salhia, Bodour, Marin, Julian, Ganesan, Shridar, Ratan, Aakrosh, Shriver, Craig, Hwu, Patrick, Dalton, William S, Weiner, George J, Conejo-Garcia, Jose R, Rodriguez, Paulo, Tarhini, Ahmad A

Volltext

Proteomic Contributions to Personalized Cancer Care von Koomen, John M., Haura, Eric B., Bepler, Gerold, Sutphen, Rebecca, Remily-Wood, Elizabeth R., Benson, Kaaron, Hussein, Mohamad, Hazlehurst, Lori A., Yeatman, Timothy J., Hildreth, Lynne T., Sellers, Thomas A., Jacobsen, Paul B., Fenstermacher, David A., Dalton, William S.

Volltext

Patient Enrichment for Precision‐Based Cancer Clinical Trials: Using Prospective Cohort Surveillance as an Approach to Improve Clinical Trials von Dalton, William S., Sullivan, Daniel, Ecsedy, Jeffrey, Caligiuri, Michael A.

Volltext

Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas von Zhang, Xinwei, Zhao, Xiaohong, Fiskus, Warren, Lin, Jianhong, Lwin, Tint, Rao, Rekha, Zhang, Yizhuo, Chan, John C, Fu, Kai, Marquez, Victor E, Chen-Kiang, Selina, Moscinski, Lynn C, Seto, Edward, Dalton, William S, Wright, Kenneth L, Sotomayor, Eduardo, Bhalla, Kapil, Tao, Jianguo

Volltext